Journal article icon

Journal article

Therapeutic targeting of HIV reservoirs: how to give T cells a new direction

Abstract:

HIV cannot be cured by current antiretroviral therapy (ART) because it persists in a transcriptionally silent form in long-lived CD4+ cells. Leading efforts to develop a functional cure have prioritized latency reversal to expose infected cells to immune surveillance, coupled with enhancement of the natural cytolytic function of immune effectors, or “kick and kill.” The most clinically advanced approach to improving the kill is therapeutic immunization, which aims to augment or re-focus HIV-s...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.3389/fimmu.2018.02861

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDM
Subgroup:
Target Discovery Institute
Wallace, Z More by this author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDM
Subgroup:
Target Discovery Institute
Publisher:
Frontiers Media Publisher's website
Journal:
Frontiers in Immunology Journal website
Volume:
9
Pages:
Article: 2861
Publication date:
2018-12-04
Acceptance date:
2018-11-20
DOI:
ISSN:
1664-3224
Pubs id:
pubs:953267
URN:
uri:6865cdfd-8f1c-465d-908a-f8f19ff29539
UUID:
uuid:6865cdfd-8f1c-465d-908a-f8f19ff29539
Local pid:
pubs:953267

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP